arginine has been researched along with Blast Phase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adamsky, K; Amariglio, N; Ashur-Fabian, O; Cohen, Y; Hardan, I; Nagler, A; Raanani, P; Rechavi, G; Trakhtenbrot, L | 1 |
Dahl, GV; Grier, HE; Kalwinsky, DK; Mason, C; Mirro, J; Murphy, SB; Santana, VM | 1 |
2 other study(ies) available for arginine and Blast Phase
Article | Year |
---|---|
Apaf1 in chronic myelogenous leukemia (CML) progression: reduced Apaf1 expression is correlated with a H179R p53 mutation during clinical blast crisis.
Topics: Apoptotic Protease-Activating Factor 1; Arginine; Blast Crisis; Gene Expression Regulation, Leukemic; Histidine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Point Mutation; Tumor Suppressor Protein p53 | 2007 |
Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukopenia; Male; Mouth Mucosa; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Stomatitis; Teniposide; Thrombocytopenia | 1989 |